BioRestorative Therapies Inc

BioRestorative Therapies Inc

BRTX

Get informed when a big investor buys or sells

+ Follow
Market Cap$3.1M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
BioRestorative Therapies IncBioRestorative Therapies Inc-0.3--365%--
$-0.44

Current Fair Value

232.1% downside

Overvalued by 232.1% based on the discounted cash flow analysis.

Share Statistics

Market cap$3.10 Million
Enterprise Value$-10,267.00
Dividend Yield$- (-)
Earnings per Share$-1.58
Beta0.64
Outstanding Shares8,993,115

Return

Return on Equity-365.43%ROE
Return on Assets-238.27%
Return on Invested Capital-471.90%

Valuation & Multiples

P/E Ratio-0.28P/E Ratio
PEG0.47PEG
Price to Sales-Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue-0.03
Enterprise Value to EBIT0
Enterprise Value to Net Income0
Total Debt to Enterprise0
Debt to Equity0Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
May 14, 2026
EPS Estimate
$-0.30
Average shareholder expectation
Revenue Estimate
$312,500
Average shareholder expectation

Next Earnings Call

Expected Date
August 11, 2026
EPS Estimate
$-0.15
Average shareholder expectation
Revenue Estimate
$600,000
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.00000%
Total Calls-
Total Puts-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %7.53%▲ 3.94%
Total Invested$184,219▼ 51.95%
Investors Holding10▼ 3.00%

ESG Score

No data

About BioRestorative Therapies Inc

5 employees
CEO: Mark Weinreb